PT
Pelthos Therapeutics Inc. (PTHS)
AMEX·Healthcare·Biotechnology
$14.60
-3.95%
Mkt Cap $15.45M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$54.50
Range $45.00 – $64.00
Implied Upside
+273.3%
Consensus $54.50 vs current $14.60
AMEX·Healthcare·Biotechnology
$14.60
-3.95%
Mkt Cap $15.45M
No recent rating data.
Price Target (9 analysts)
$54.50
Range $45.00 – $64.00
+273.3%
Consensus $54.50 vs current $14.60